UniProt ID | ELK3_HUMAN | |
---|---|---|
UniProt AC | P41970 | |
Protein Name | ETS domain-containing protein Elk-3 | |
Gene Name | ELK3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 407 | |
Subcellular Localization | Nucleus. | |
Protein Description | May be a negative regulator of transcription, but can activate transcription when coexpressed with Ras, Src or Mos. Forms a ternary complex with the serum response factor and the ETS and SRF motifs of the Fos serum response element.. | |
Protein Sequence | MESAITLWQFLLQLLLDQKHEHLICWTSNDGEFKLLKAEEVAKLWGLRKNKTNMNYDKLSRALRYYYDKNIIKKVIGQKFVYKFVSFPEILKMDPHAVEISRESLLLQDSDCKASPEGREAHKHGLAALRSTSRNEYIHSGLYSSFTINSLQNPPDAFKAIKTEKLEEPPEDSPPVEEVRTVIRFVTNKTDKHVTRPVVSLPSTSEAAAASAFLASSVSAKISSLMLPNAASISSASPFSSRSPSLSPNSPLPSEHRSLFLEAACHDSDSLEPLNLSSGSKTKSPSLPPKAKKPKGLEISAPPLVLSGTDIGSIALNSPALPSGSLTPAFFTAQTPNGLLLTPSPLLSSIHFWSSLSPVAPLSPARLQGPSTLFQFPTLLNGHMPVPIPSLDRAASPVLLSSNSQKS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MESAITLWQF -----CHHHHHHHHH | 24.55 | 27732954 | |
6 | Phosphorylation | --MESAITLWQFLLQ --CHHHHHHHHHHHH | 22.97 | 27732954 | |
56 | Phosphorylation | KNKTNMNYDKLSRAL CCCCCCCHHHHHHHH | 12.04 | - | |
58 | Ubiquitination | KTNMNYDKLSRALRY CCCCCHHHHHHHHHH | 37.69 | - | |
83 | Ubiquitination | IGQKFVYKFVSFPEI HCCCHHEEECCHHHH | 33.71 | - | |
92 | Ubiquitination | VSFPEILKMDPHAVE CCHHHHHCCCHHHHH | 47.09 | 21906983 | |
92 | Sumoylation | VSFPEILKMDPHAVE CCHHHHHCCCHHHHH | 47.09 | 28112733 | |
104 | Phosphorylation | AVEISRESLLLQDSD HHHCCHHHHHCCCCC | 24.17 | 23403867 | |
110 | Phosphorylation | ESLLLQDSDCKASPE HHHHCCCCCCCCCCC | 31.76 | 30266825 | |
113 | Ubiquitination | LLQDSDCKASPEGRE HCCCCCCCCCCCHHH | 57.81 | - | |
115 | Phosphorylation | QDSDCKASPEGREAH CCCCCCCCCCHHHHH | 14.69 | 23401153 | |
131 | Phosphorylation | HGLAALRSTSRNEYI HHHHHHHCCCCCCCC | 31.42 | 27251275 | |
132 | Phosphorylation | GLAALRSTSRNEYIH HHHHHHCCCCCCCCC | 25.85 | 27251275 | |
133 | Phosphorylation | LAALRSTSRNEYIHS HHHHHCCCCCCCCCC | 34.06 | 27251275 | |
137 | Phosphorylation | RSTSRNEYIHSGLYS HCCCCCCCCCCCCCC | 13.90 | 29978859 | |
140 | Phosphorylation | SRNEYIHSGLYSSFT CCCCCCCCCCCCCCE | 22.42 | 29978859 | |
143 | Phosphorylation | EYIHSGLYSSFTINS CCCCCCCCCCCEECC | 13.04 | 29978859 | |
144 | Phosphorylation | YIHSGLYSSFTINSL CCCCCCCCCCEECCC | 24.82 | 29978859 | |
145 | Phosphorylation | IHSGLYSSFTINSLQ CCCCCCCCCEECCCC | 16.92 | 29978859 | |
147 | Phosphorylation | SGLYSSFTINSLQNP CCCCCCCEECCCCCC | 22.61 | 29978859 | |
150 | Phosphorylation | YSSFTINSLQNPPDA CCCCEECCCCCCCHH | 27.73 | 29978859 | |
162 | Sumoylation | PDAFKAIKTEKLEEP CHHHHHHHHHCCCCC | 56.33 | - | |
162 | Sumoylation | PDAFKAIKTEKLEEP CHHHHHHHHHCCCCC | 56.33 | - | |
165 | Sumoylation | FKAIKTEKLEEPPED HHHHHHHCCCCCCCC | 67.44 | 28112733 | |
165 | Ubiquitination | FKAIKTEKLEEPPED HHHHHHHCCCCCCCC | 67.44 | - | |
173 | Phosphorylation | LEEPPEDSPPVEEVR CCCCCCCCCCHHHHH | 29.46 | 23401153 | |
189 | Acetylation | VIRFVTNKTDKHVTR HHHHHHCCCCCCCCC | 49.05 | 18584403 | |
195 | O-linked_Glycosylation | NKTDKHVTRPVVSLP CCCCCCCCCCEECCC | 29.04 | 29351928 | |
200 | O-linked_Glycosylation | HVTRPVVSLPSTSEA CCCCCEECCCCHHHH | 34.49 | 29351928 | |
203 | O-linked_Glycosylation | RPVVSLPSTSEAAAA CCEECCCCHHHHHHH | 50.27 | 29351928 | |
204 | O-linked_Glycosylation | PVVSLPSTSEAAAAS CEECCCCHHHHHHHH | 28.75 | 29351928 | |
205 | O-linked_Glycosylation | VVSLPSTSEAAAASA EECCCCHHHHHHHHH | 29.58 | 29351928 | |
211 | O-linked_Glycosylation | TSEAAAASAFLASSV HHHHHHHHHHHHHHH | 18.15 | 29351928 | |
240 | Phosphorylation | ISSASPFSSRSPSLS CCCCCCCCCCCCCCC | 28.38 | 24247654 | |
243 | Phosphorylation | ASPFSSRSPSLSPNS CCCCCCCCCCCCCCC | 22.31 | 30266825 | |
245 | Phosphorylation | PFSSRSPSLSPNSPL CCCCCCCCCCCCCCC | 42.60 | 30266825 | |
247 | Phosphorylation | SSRSPSLSPNSPLPS CCCCCCCCCCCCCCH | 26.77 | 30266825 | |
250 | Phosphorylation | SPSLSPNSPLPSEHR CCCCCCCCCCCHHHH | 31.06 | 30266825 | |
254 | Phosphorylation | SPNSPLPSEHRSLFL CCCCCCCHHHHHHHH | 54.43 | 27732954 | |
258 | Phosphorylation | PLPSEHRSLFLEAAC CCCHHHHHHHHHHHC | 25.94 | 27732954 | |
268 | Phosphorylation | LEAACHDSDSLEPLN HHHHCCCCCCCCCCC | 12.87 | 27732954 | |
270 | Phosphorylation | AACHDSDSLEPLNLS HHCCCCCCCCCCCCC | 38.29 | 27732954 | |
282 | Phosphorylation | NLSSGSKTKSPSLPP CCCCCCCCCCCCCCC | 38.15 | 23403867 | |
284 | Phosphorylation | SSGSKTKSPSLPPKA CCCCCCCCCCCCCCC | 25.59 | 26657352 | |
286 | Phosphorylation | GSKTKSPSLPPKAKK CCCCCCCCCCCCCCC | 61.67 | 23403867 | |
357 | Phosphorylation | IHFWSSLSPVAPLSP HHHHHCCCCCCCCCH | 21.19 | 11042694 | |
363 | Phosphorylation | LSPVAPLSPARLQGP CCCCCCCCHHHHCCC | 18.56 | 11042694 | |
396 | Phosphorylation | PSLDRAASPVLLSSN CCCCCCCCCEEECCC | 17.98 | 29255136 | |
401 | Phosphorylation | AASPVLLSSNSQKS- CCCCEEECCCCCCC- | 24.26 | 30266825 | |
402 | Phosphorylation | ASPVLLSSNSQKS-- CCCEEECCCCCCC-- | 40.23 | 23403867 | |
404 | Phosphorylation | PVLLSSNSQKS---- CEEECCCCCCC---- | 40.72 | 23403867 | |
407 | Phosphorylation | LSSNSQKS------- ECCCCCCC------- | 37.50 | 23403867 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
357 | S | Phosphorylation | Kinase | JNK-SUBFAMILY | - | GPS |
357 | S | Phosphorylation | Kinase | JNK_GROUP | - | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ELK3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ELK3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TFE2_HUMAN | TCF3 | physical | 8918463 | |
A4_HUMAN | APP | physical | 21832049 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-396, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND MASSSPECTROMETRY. |